How a small Peninsula company plans to take a big bite out of the pet drug market


Long-acting injectables of existing pet drugs could make life easier for pet parents, said Lifescient founder and CEO Kamalesh Rao, and drive more revenue for vet offices.

Previous Biogen's 1,000-person layoff begins in Cambridge
Next The Cupertino cement plant has been permanently closed. Here's what it could be next.